Advertisement

Topics

Global Human Albumin Market 20162020 Prices from USD $2500

13:39 EST 1 Dec 2016 | BioPortfolio Reports

About the Human Albumin Market

Albuminbased therapies such as Idelvion CSL654 rIXFP by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin TV1106 by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols for Alzheimer's disease are expected to enter the market during the forecast period.
The demand for albumin is high in APAC in countries like India and China. Still, the uptake of these therapeutics is less due to the lack of awareness about these products and their therapeutic uses. Thus, the awareness programs conducted by organizations such as PPTA, which includes International Plasma Awareness Week, to help increase the awareness about plasma donation and the different plasma protein therapies available, along with their potential uses, is expected to increase the uptake of these therapeutics in treating various conditions.

Technavio's analysts forecast the global human albumin market to grow at a CAGR of 4.97% during the period 20162020.

Covered in this report
The report covers the present scenario and the growth prospects of the global human albumin market for 20162020. To calculate the market size, the report considers revenue generated from the sales of branded and generic albumin drugs used to treat infections, liver diseases, shock, during surgery, and severe burns. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Human Albumin Market 20162020, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
CSL Behring
Grifols
Baxalta
Octapharma
Kedrion

Other prominent vendors
AADi
Ablynx
Albumedix
Ampio Pharmaceuticals
Azaya Therapeutics
Beijing Tiantan
Biotest
BristolMyers Squibb
Celgene
ConjuChem
GSK
Hebei Changshan Biochem Pharma
HiMedia Laboratories
Hualan Biological Engineering
InVittria
MedxBio
Merck
Mitsubishi Tanabe Pharma
NantBioScience
Novo Nordisk
Novozymes
Shanghai RAAS Blood Products
Sucampo Pharmaceuticals
Teva Pharmaceuticals
Thermo Fisher Scientific
Tianjin SinoBiotech Beijing BioFortune
Ventria Bioscience
Yoshitomi Pharmaceutical

Market driver
High demand for human albumin in China
For a full, detailed list, view our report

Market challenge
Spread of pathogenic contaminants
For a full, detailed list, view our report

Market trend
Rise in nontherapeutic applications
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Original Article: Global Human Albumin Market 20162020 Prices from USD $2500

NEXT ARTICLE

More From BioPortfolio on "Global Human Albumin Market 20162020 Prices from USD $2500"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...